Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Intimation for Board Meeting Intimation For Considering And Approving The Unaudited Financial Results For The Company For The Quarter And Nine Months Ending December 31, 2023

DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 ,inter alia, to consider and approve The unaudited financial results for the Company for the quarter and nine months ending December 31, 2023
21-12-2023
Bigul

Dr. Reddy's named in S&P Dow Jones sustainability index

Dr. Reddy's Laboratories wins global recognition for sustainability and ESG agenda
14-12-2023

Dr Reddy's share price gain 2.96% as concerns raised around its FTO-3 facility ease

Stock Market Today: Dr Reddy's share price rebounded on Tuesday, gaining 2.96% after having corrected more than 5% on Monday post regulatory concerns were raised around its FTO3 facility.
12-12-2023
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Clarification On Reported News Article

Clarification on reported news article
12-12-2023
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Issuance of Letter of confirmation in lieu of share certificate(s) lost/misplaced
11-12-2023

Dr Reddy's slumps 7% on US FDA's 'severe' observations for Telangana unit

Antique Broking estimates the Bachupally unit contributes nearly 30 percent to Dr Reddy's US revenue and adverse observations could lead to a warning letter
11-12-2023
Bigul

DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation

Intimation regarding completion of USFDA inspection
08-12-2023
Next Page
Close

Let's Open Free Demat Account